Advaxis, a biotechnology company developing the next generation of cancer immunotherapies, has expanded its relationship by entering into a master clinical trial agreement with GRU Cancer Center at Georgia Regents University to conduct four Phase I/II clinical trials.
Radon is a gaseous radioactive element. It is an extremely toxic, colorless gas, derived from the radioactive decay of radium, uranium and thorium. It is used in cancer treatment. It has been considered by the Environmental Protection Agency as the second most leading cause of lung cance r after cigarette smoking based on their mathematical risk estimates derived from many published studies.
Steve Jobs has battled a rare form of pancreatic cancer for years, undergoing a series of aggressive treatments, including a liver transplant, and surviving longer than many others with the disease.
"Losing Is Not An Option. Fight Like a Women "
Breast cancer is a serious disease that affects millions of people and their loved ones each year. It can come to you too. But don't loose hope. Dr. Steven Quay, the CEO of Atossa Therapeutics Inc. is here to show you the ways to prevent Breast Cancer.
There are many terms used to refer to these treatments, but all mean the same thing. Some of these terminologies and definitions include 'unorthodox, 'unconventional', 'alternative' and even more recently 'complementary.'
We might think that all anticancer treatment is to be always administered via needles, cannula, and drip sets. However, there are anti-cancer medicines that can be given via mouth. This can be simply called oral Chemotherapy anticancer treatment.
The Department of Health and Social Care (DHSC) has invited views of healthcare professionals and others to tackle the six major health conditions which
drive-ill health and contribute to the burden of disease in England.
The six major health conditions - cancer; cardiovascular diseases including stroke and diabetes; chronic respiratory diseases; dementia; mental ill-health and
musculoskeletal disorders - affect millions of people in England with data showing that one in four suffer from two or more of these major long-term conditions.
Recognising the pressure these conditions are putting on the NHS, the government is seeking views on a new strategy to tackle them that will focus not only on
treatment but also on prevention.
Government is particularly interested in hearing from those who suffer from, care for or provide treatment to people who suffer from multiple long-term conditions.
This is to ensure the Major Conditions Strategy is one that will better prevent, diagnose, manage and treat these conditions.
Contributions are also encouraged from those working in NHS bodies, local government, the voluntary and community sector, and wider industry, on how best to tackle
suffering from one or more of these major conditions. Particularly, it is seeking perspectives on how government and the NHS can work better together with different
organisations and sectors to improve the nation's health.
Living with diabetes can be managed by proper medication. However, you may have questions regarding the medications available to you. Here, we will take a
closer look at two medications, Ozempic and Saxenda, so that you can see how these medications can impact your health.
A CLOSER LOOK AT DIABETES
Diabetes can be divided into two categories, type 1 diabetes (T1D) and type 2 diabetes (T2D).
Type 1 diabetes is an autoimmune disorder and is commonly diagnosed in children. Individuals with T1D require lifelong insulin treatment to manage their diabetes.
Type 2 diabetes is diagnosed later in life due to genetics, lifestyle, and other risk factors. Unlike T1D, there are numerous treatment options other than insulin
therapy to manage type 2 diabetes.
GLP-1 RECEPTOR AGONISTS
A common drug class used to treat type 2 diabetes is glucagon-like peptide 1 (GLP-1) receptor agonists. GLP-1 receptor agonists work by lowering blood glucose and
slowing gastric emptying. Benefits of using a GLP-1 receptor agonist include: weight loss, atherosclerotic cardiovascular disease (ASCVD) benefits, lowering A1C
values, and chronic kidney disease (CKD) benefits with little risk of hypoglycemia. Common GLP-1 receptor agonist side effects include nausea, vomiting, diarrhea,
weight loss, and injection site reactions. GLP-1 receptor agonists should not be used in patients with a personal or a family history of medullary thyroid cancer.
The UK Government is investing £100 million to accelerate the use of AI in life sciences and healthcare under a new mission.
UK Prime Minister Rishi Sunak announced the AI Life Sciences Accelerator Mission in his speech last week.
The new initiative will capitalise on the UK's unique strengths in securing "health data and cutting-edge AI."
It will also help to identify those at risk of "dementia" and will ensure that patients participate in the trials at the right time to develop new treatments
effectively.
Henceforth, it will provide us with better data on how well new therapies work.
Sunak said: "AI can help us solve some of the greatest social challenges of our time. AI could help find novel dementia treatments or develop vaccines for cancer."
Adding to the growing evidence of global medicine shortages, a new study has revealed that the European generic medicines market is "not in shape" to help
Europe meet its public health priorities.
In the past decade, the rate of generic medicines withdrawals has risen by 12 per cent, while there has been a three per cent decrease in the launch of generic
products, as per Teva Pharmaceuticals' recent analysis of IQVIA data.
Within the mental therapeutic area, seven per cent of generic products disappeared between 2013 and 2023, while there was a seven per cent decrease in the
availability of generic cancer medicines in just six years (2017-2022).
These medicines were listed on the Union List of Critical Medicines to help avoid potential shortages, as the European Commission (EC) said this could cause
"significant harm to patients and pose important challenges to health systems."
While mature generic products constitute the majority of the List, they remain susceptible to withdrawals, despite containing products crucial for safeguarding
Europe's public health, the Teva analysis report noted.
Since 2013, the number of generic products for the treatment of schizophrenia and bipolar disorder has declined by 25 per cent, with Hungary and Bulgaria
experiencing the biggest loss at 83 per cent and 58 per cent respectively.
Get your swimsuit body ready for this summer by getting a perfect tanning treatment in Drogheda. Exposure to the sun can cause our skin to age prematurely but harmful UV rays can result in skin cancers. Also that bottles of self-tanning lotion hastily applied in our bathrooms the day before an important event can lead to untold embarrassments. So, of course, getting your tan done professionally is the safest, most convenient way of getting that healthy sun-kissed glow. Here, at Lanu Medi Spa, we have Top Tips for getting the perfect tan every time and maintaining your sun tan for longer.
Scottish biotechnology firm TC BioPharm (TCB) and Japanese immuno-cell therapy company Medinet have entered into a strategic collaboration to develop a new treatment for different types of cancer.
Obesity is defined by body mass index more than 30. Body mass index is derived from your weight and height. Obesity is now rising across many countries in the world including India. It is said to have reached an epidemic proportion in our country with 5 % of the population being morbidly obese.
बहुत कम लोगो को पता है की हमारे शरीर की इम्युनिटी या प्रतिरोध क्षमता ना केवल इन्फेक्शन बल्कि कैंसर से भी लड़ती है, शरीर में कैंसर बढ़ने से भी रोकती है। जब भी हमारे शरीर में कैंसर बनने लगता है तो इम्युनिटी प्रयास करती है की कैंसर ख़त्म हो जाय।